GlassScriptPhysician profile
Madison Dastis
NPI 1467056507
$3,931.89
in general payments reported to CMS, 2019-2025
24 companies · $626 in 2025
The $626 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $461 · 2022: $1,206 · 2023: $1,166 · 2024: $472 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,209 · Education: $54.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,209.36 |
| Education | $54.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,008.65 | 2021-2025 | |
| Glaxosmithkline, LLC. | $931.25 | 2021-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $805.73 | 2021-2024 | Tezspire, Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.74 | 2022-2024 | Ofev, Stiolto Respimat |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $193.31 | 2023 | Lifevest |
| Sanofi-Aventis U.S. LLC | $136.94 | 2022-2024 | |
| Philips North America LLC | $117.76 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $81.12 | 2022-2025 | Dupixent |
| Optinose US, INC. | $72.00 | 2024-2025 | |
| Amgen INC. | $54.63 | 2021-2022 | |
| Irhythm Technologies, INC. | $32.83 | 2024 | Zio Xt Patch, Zio Monitor |
| Mylan Specialty L.P. | $31.86 | 2022-2023 | Yupelri |
| Merck Sharp & Dohme LLC | $31.76 | 2022-2023 | Belsomra |
| United Therapeutics Corporation | $29.79 | 2024 | Tyvaso |
| Teva Pharmaceuticals USA, INC. | $25.41 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $19.22 | 2024 | |
| Paratek Pharmaceuticals, INC. | $18.73 | 2025 | Xhance |
| Harmony Biosciences LLC | $16.92 | 2023 | Wakix |
| Inogen, INC. | $16.92 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Novartis Pharmaceuticals Corporation | $15.84 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.83 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.76 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.47 | 2021 | |
| Phathom Pharmaceuticals, INC. | $14.42 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Dastis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.